Evidence map›Paper›PMID 30680827›Full record

ArticleInternational journal of experimental pathology2018

Non-alcoholic steatohepatitis aggravates nitric oxide synthase inhibition-induced arteriosclerosis in SHRSP5/Dmcr rat model.

Shogo Watanabe, Shota Kumazaki, Shusei Yamamoto, Ikumi Sato, Kazuya Kitamori, Mari Mori, Yukio Yamori, Satoshi Hirohata

Open access · greenAbstract read
In one paragraph

Article in International journal of experimental pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Ectopic Fat Accumulation in Pancreas and Heart.Journal of clinical medicine · 2021
    Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Shogo WatanabeDepartment of Medical Technology, Graduate School of Health Sciences, Okayama University, Okayama, Japan.ORCID 0000-0002-1700-2892
Shota KumazakiDepartment of Medical Technology, Graduate School of Health Sciences, Okayama University, Okayama, Japan.
Shusei YamamotoDepartment of Medical Technology, Graduate School of Health Sciences, Okayama University, Okayama, Japan.
Ikumi SatoDepartment of Medical Technology, Graduate School of Health Sciences, Okayama University, Okayama, Japan.
Kazuya KitamoriCollege of Human Life and Environment, Kinjo Gakuin University, Nagoya, Japan.
Mari MoriDepartment of Health Management, School of Health Studies, Tokai University, Kanagawa, Japan.
Yukio YamoriInstitute for World Health Development, Mukogawa Women's University, Hyogo, Japan.
Satoshi HirohataDepartment of Medical Technology, Graduate School of Health Sciences, Okayama University, Okayama, Japan.
Okayama University · JPKinjo Gakuin University · JPMukogawa Women's University · JPTokai University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-alcoholic steatohepatitis (NASH) is linked to increased cardiovascular risk, independent of the broad spectrum of metabolic syndrome risk factors. Stroke-prone (SP) spontaneously hypertensive rats (SHRSP5/Dmcr) fed a high-fat and high-cholesterol (HFC) diet developed hepatic lesions similar to those in human NASH pathology. These rats simultaneously developed lipid deposits in the mesenteric arteries, cardiac fibrosis, endothelial dysfunction and left ventricle (LV) diastolic dysfunction. However, the intermediary factors between NASH and cardiovascular disease are still unknown. We investigated whether NASH aggravates nitric oxide (NO) synthase inhibition-induced arteriosclerosis in SHRSP5/Dmcr rats. Wistar Kyoto and SHRSP5/Dmcr rats were divided into 4 groups of 5 and fed the stroke-prone (SP) or HFC diets for 8 weeks. To induce NO synthase inhibition, N

Indexed as

AnimalsArteriosclerosisDiet, High-FatDisease Models, AnimalEndothelium, VascularHeart VentriclesLiverMaleMyocardial IschemiaNG-Nitroarginine Methyl EsterNitric Oxide SynthaseNon-alcoholic Fatty Liver DiseaseOrgan SizeRats, Inbred SHRRats, Inbred WKYVentricular Dysfunction, LeftNG-Nitroarginine Methyl EsterNitric Oxide Synthaseatherosclerosisendothelial functionmyocardial ischaemianon-alcoholic steatohepatitisSHRSP5/Dmcr

Identifiers

PMID30680827
PMCPMC6384504
OpenAlexW2914249003

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.